Predictors of human papilloma virus (HPV) infection in Italian women
HPV infection is a "necessary cause" of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for infection is the basis to implement prophylactic strategy even in older women. The aim of the study was to evaluate predictors of high-...
Saved in:
| Published in: | Journal of medical virology Vol. 82; no. 11; pp. 1921 - 1927 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-11-2010
Wiley Wiley-Blackwell |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | HPV infection is a "necessary cause" of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for infection is the basis to implement prophylactic strategy even in older women. The aim of the study was to evaluate predictors of high-risk (HR) HPV infection in adult women. Between 2006 and 2008, 100 women aged >18 years, with no previous treatment for cervical lesions, were screened for HR HPV infection in Rome, Italy. Risk factors for HPV infection were investigated through a questionnaire including: ethnicity, religion, education, marital status, sexual behavior, gynecological and obstetrical history, smoking and alcohol intake. Multivariate analysis identified the "never married-separated/divorced" status (OR: 3.38; 95% CI: 1.14-10.12) as predictor of HPV infection, while having a higher age at the first sexual intercourse (FSI) shows a protective effect (OR: 0.84; 95% CI: 0.71-1.00). A trend for the association between the infection and having more than three lifetime partners was also observed (OR: 2.57; 95% CI: 0.86-7.71). No significant association was found for other demographic characteristics investigated. These findings provide a contribution in the knowledge of an adult population defining a "high-risk" sexual behavioral profile and could be helpful to target prophylactic strategies in older woman. J. Med. Virol. 82:1921-1927, 2010. |
|---|---|
| AbstractList | HPV infection is a "necessary cause" of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for infection is the basis to implement prophylactic strategy even in older women. The aim of the study was to evaluate predictors of high-risk (HR) HPV infection in adult women. Between 2006 and 2008, 100 women aged >18 years, with no previous treatment for cervical lesions, were screened for HR HPV infection in Rome, Italy. Risk factors for HPV infection were investigated through a questionnaire including: ethnicity, religion, education, marital status, sexual behavior, gynecological and obstetrical history, smoking and alcohol intake. Multivariate analysis identified the "never married-separated/divorced" status (OR: 3.38; 95% CI: 1.14-10.12) as predictor of HPV infection, while having a higher age at the first sexual intercourse (FSI) shows a protective effect (OR: 0.84; 95% CI: 0.71-1.00). A trend for the association between the infection and having more than three lifetime partners was also observed (OR: 2.57; 95% CI: 0.86-7.71). No significant association was found for other demographic characteristics investigated. These findings provide a contribution in the knowledge of an adult population defining a "high-risk" sexual behavioral profile and could be helpful to target prophylactic strategies in older woman. HPV infection is a “necessary cause” of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for infection is the basis to implement prophylactic strategy even in older women. The aim of the study was to evaluate predictors of high‐risk (HR) HPV infection in adult women. Between 2006 and 2008, 100 women aged >18 years, with no previous treatment for cervical lesions, were screened for HR HPV infection in Rome, Italy. Risk factors for HPV infection were investigated through a questionnaire including: ethnicity, religion, education, marital status, sexual behavior, gynecological and obstetrical history, smoking and alcohol intake. Multivariate analysis identified the “never married–separated/divorced” status (OR: 3.38; 95% CI: 1.14–10.12) as predictor of HPV infection, while having a higher age at the first sexual intercourse (FSI) shows a protective effect (OR: 0.84; 95% CI: 0.71–1.00). A trend for the association between the infection and having more than three lifetime partners was also observed (OR: 2.57; 95% CI: 0.86–7.71). No significant association was found for other demographic characteristics investigated. These findings provide a contribution in the knowledge of an adult population defining a “high‐risk” sexual behavioral profile and could be helpful to target prophylactic strategies in older woman. J. Med. Virol. 82:1921–1927, 2010. © 2010 Wiley‐Liss, Inc. HPV infection is a "necessary cause" of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for infection is the basis to implement prophylactic strategy even in older women. The aim of the study was to evaluate predictors of high-risk (HR) HPV infection in adult women. Between 2006 and 2008, 100 women aged >18 years, with no previous treatment for cervical lesions, were screened for HR HPV infection in Rome, Italy. Risk factors for HPV infection were investigated through a questionnaire including: ethnicity, religion, education, marital status, sexual behavior, gynecological and obstetrical history, smoking and alcohol intake. Multivariate analysis identified the "never married-separated/divorced" status (OR: 3.38; 95% CI: 1.14-10.12) as predictor of HPV infection, while having a higher age at the first sexual intercourse (FSI) shows a protective effect (OR: 0.84; 95% CI: 0.71-1.00). A trend for the association between the infection and having more than three lifetime partners was also observed (OR: 2.57; 95% CI: 0.86-7.71). No significant association was found for other demographic characteristics investigated. These findings provide a contribution in the knowledge of an adult population defining a "high-risk" sexual behavioral profile and could be helpful to target prophylactic strategies in older woman. J. Med. Virol. 82:1921-1927, 2010. HPV infection is a "necessary cause" of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for infection is the basis to implement prophylactic strategy even in older women. The aim of the study was to evaluate predictors of high-risk (HR) HPV infection in adult women. Between 2006 and 2008, 100 women aged >18 years, with no previous treatment for cervical lesions, were screened for HR HPV infection in Rome, Italy. Risk factors for HPV infection were investigated through a questionnaire including: ethnicity, religion, education, marital status, sexual behavior, gynecological and obstetrical history, smoking and alcohol intake. Multivariate analysis identified the "never married-separated/divorced" status (OR: 3.38; 95% CI: 1.14-10.12) as predictor of HPV infection, while having a higher age at the first sexual intercourse (FSI) shows a protective effect (OR: 0.84; 95% CI: 0.71-1.00). A trend for the association between the infection and having more than three lifetime partners was also observed (OR: 2.57; 95% CI: 0.86-7.71). No significant association was found for other demographic characteristics investigated. These findings provide a contribution in the knowledge of an adult population defining a "high-risk" sexual behavioral profile and could be helpful to target prophylactic strategies in older woman. Background: HPV infection is a “necessary cause” of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for infection is the basis to implement prophylactic strategy even in older women. Objective: The aim of the study was to evaluate predictors of high-risk HPV infection in adult women. Methods: Between 2006 and 2008, one hundred women aged >18 years, with no previous treatment for cervical lesions, were screened for high-risk HPV infection in Rome, Italy. Risk factors for HPV infection were investigated through a questionnaire including: ethnicity, religion, education, marital status, sexual behavior, gynecological and obstetrical history, smoking and alcohol intake. Results: Multivariate analysis identified the “never married-separated/divorced” status (OR: 3.38; 95% CI: 1.14-10.12) as predictor of HPV infection, while having a higher age at the first sexual intercourse shows a protective effect (OR: 0.84; 95% CI: 0.71-1.00). A trend for the association between the infection and having more than three lifetime partners was also observed (OR: 2,57; 95% CI: 0.86-7.71). No significant association was found for other demographic characteristics investigated. Conclusions: These findings provide a contribution in the knowledge of an adult population defining a “high risk” sexual behavioural profile and could be helpful to target prophylactic strategies in older woman. |
| Author | Vocaturo, A. Carrone, A. Paolini, F. Rollo, F. Morano, G. Mariani, L. Venuti, A. Germelli, C. Terrenato, I. Benevolo, M. Cercato, M.C. |
| Author_xml | – sequence: 1 fullname: Cercato, M.C – sequence: 2 fullname: Mariani, L – sequence: 3 fullname: Vocaturo, A – sequence: 4 fullname: Carrone, A – sequence: 5 fullname: Terrenato, I – sequence: 6 fullname: Morano, G – sequence: 7 fullname: Benevolo, M – sequence: 8 fullname: Rollo, F – sequence: 9 fullname: Germelli, C – sequence: 10 fullname: Paolini, F – sequence: 11 fullname: Venuti, A |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23253501$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20872720$$D View this record in MEDLINE/PubMed https://hal.science/hal-00577347$$DView record in HAL |
| BookMark | eNp1kMFu1DAURS1URKeFBT8A2SDoIu2zHcfOskyhUzSFImiR2FiOY1O3STzYmSn9ezxkOl2x8pN13r1PZw_t9L43CL3EcIgByNFNtzokWAj-BE0wVGVeAcc7aAK4KPOyxGwX7cV4AwCiIuQZ2iUgOOEEJujkIpjG6cGHmHmbXS871WcLtXBt6zuVrVxYxuzd7OLqIHO9NXpwvk9Tdjao1iX0znemf46eWtVG82Lz7qPLjx--T2f5_Mvp2fR4nutCMJ6XIGjBSc0ss4UqmyJNmldcKFYX0NR1qazVgqq6Acy0KYCKmlcWSlsQIQTdRwdj7rVq5SK4ToV76ZWTs-O5XP8BMM5Txwon9u3ILoL_vTRxkJ2L2rSt6o1fRskZK5IPTB9TdfAxBmO30Rjk2q9MfuU_v4l9tUld1p1ptuSD0AS82QAqatXaoHrt4iNHCaMM1ucdjdyda839_xvlp_Orh-p83HBxMH-2GyrcypJTzuSPz6fy5Fx85e9_TuVa1uuRt8pL9SukKy6_kVQNWFSUCEL_Ar1aqSo |
| CODEN | JMVIDB |
| CitedBy_id | crossref_primary_10_1177_0956462414528315 crossref_primary_10_1371_journal_pone_0132462 crossref_primary_10_1515_ii_2017_0128 crossref_primary_10_1089_jwh_2020_8656 crossref_primary_10_1007_s00384_014_1922_y crossref_primary_10_1186_s13027_015_0011_3 crossref_primary_10_23736_S0026_4784_20_04506_2 |
| Cites_doi | 10.1016/S0140-6736(09)61248-4 10.1207/S15324796ABM2602_03 10.1016/S1470-2045(05)70101-7 10.1038/sj.bjc.6603469 10.1093/jnci/djp367 10.1016/j.jadohealth.2008.07.009 10.1016/j.vaccine.2006.05.031 10.1371/journal.pone.0003743 10.1016/j.ygyno.2009.09.021 10.1002/jmv.21575 10.1093/jnci/95.6.E2 10.1016/S0140-6736(07)60852-6 10.1016/j.vaccine.2008.01.013 10.1016/j.vaccine.2006.05.115 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10.1158/1055-9965.1574.13.10 10.1054/bjoc.2001.1779 10.1158/1055-9965.EPI-05-0577 10.1128/JCM.38.1.357-361.2000 10.1016/j.vaccine.2008.10.088 10.1016/S0140-6736(06)68439-0 10.1093/oxfordjournals.jncimonographs.a003479 10.1016/S0140-6736(07)61684-5 10.1002/path.1866 10.1016/j.vaccine.2008.06.008 10.1080/135952201753337149 10.1093/aje/kwf180 10.1016/S0140-6736(04)17398-4 10.1002/(SICI)1098-0997(1999)7:5<237::AID-IDOG6>3.0.CO;2-4 10.1016/j.jhealeco.2004.02.001 10.1128/JCM.40.3.902-907.2002 10.1016/j.vaccine.2008.05.064 |
| ContentType | Journal Article |
| Copyright | Copyright © 2010 Wiley‐Liss, Inc. 2015 INIST-CNRS 2010 Wiley-Liss, Inc. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: Copyright © 2010 Wiley‐Liss, Inc. – notice: 2015 INIST-CNRS – notice: 2010 Wiley-Liss, Inc. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | FBQ BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 1XC VOOES |
| DOI | 10.1002/jmv.21887 |
| DatabaseName | AGRIS Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1096-9071 |
| EndPage | 1927 |
| ExternalDocumentID | oai_HAL_hal_00577347v1 10_1002_jmv_21887 20872720 23253501 JMV21887 ark_67375_WNG_DM8Q7BZC_8 US201301893282 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Italy |
| GeographicLocations_xml | – name: Italy |
| GrantInformation_xml | – fundername: The Italian Ministry of Health (partial support) |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3O- 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIJN ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEQTP AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHMBA AI. AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS ECGQY EJD ELTNK EMOBN F00 F01 F04 F5P FBQ FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E VH1 W8V W99 WBKPD WHG WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~KM ~WT AHBTC AITYG BSCLL HGLYW OIG 08R AAUGY IQODW CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7X8 1XC VOOES |
| ID | FETCH-LOGICAL-c4857-6083472b5f5f4a6d4b5fc7978a5b40dbb6affc83abd015ce4038b79f06f428883 |
| IEDL.DBID | 33P |
| ISSN | 0146-6615 |
| IngestDate | Tue Oct 15 15:37:32 EDT 2024 Sat Aug 17 01:39:28 EDT 2024 Thu Nov 21 21:19:24 EST 2024 Sat Sep 28 07:57:34 EDT 2024 Sun Oct 22 16:07:33 EDT 2023 Sat Aug 24 00:45:52 EDT 2024 Wed Oct 30 09:47:48 EDT 2024 Wed Dec 27 19:05:41 EST 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Human questionnaire risk factors Malignant tumor Epidemiology Female genital diseases HPV Infection sexual behavior Viral disease Risk factor Female Papilloma Benign neoplasm Uterine cervix diseases Cervical cancer Cancer Medicine |
| Language | English |
| License | CC BY 4.0 2010 Wiley-Liss, Inc. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4857-6083472b5f5f4a6d4b5fc7978a5b40dbb6affc83abd015ce4038b79f06f428883 |
| Notes | http://dx.doi.org/10.1002/jmv.21887 ark:/67375/WNG-DM8Q7BZC-8 The authors have no conflict of interest to disclose. The Italian Ministry of Health (partial support) istex:716333853C4398A1817E93D34458F11721FCABF7 ArticleID:JMV21887 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://hal.science/hal-00577347 |
| PMID | 20872720 |
| PQID | 755400813 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | hal_primary_oai_HAL_hal_00577347v1 proquest_miscellaneous_755400813 crossref_primary_10_1002_jmv_21887 pubmed_primary_20872720 pascalfrancis_primary_23253501 wiley_primary_10_1002_jmv_21887_JMV21887 istex_primary_ark_67375_WNG_DM8Q7BZC_8 fao_agris_US201301893282 |
| PublicationCentury | 2000 |
| PublicationDate | November 2010 |
| PublicationDateYYYYMMDD | 2010-11-01 |
| PublicationDate_xml | – month: 11 year: 2010 text: November 2010 |
| PublicationDecade | 2010 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
| PublicationTitle | Journal of medical virology |
| PublicationTitleAlternate | J. Med. Virol |
| PublicationYear | 2010 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley Wiley-Blackwell |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley – name: Wiley-Blackwell |
| References | Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, Olsson SE, Høye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, Krogh G, Lehtinen M, Malm C, Tamms GM, Giacoletti K, Lupinacci L, Railkar R, Taddeo FJ, Bryan J, Esser MT, Sings HL, Saah AJ, Barr E. 2006. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95: 1459-1466. Bosch FX, de Sanjosé S. 2003. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31: 3-13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. 2000. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361. Smith JS, Melendy A, Rana RK, Pimenta JM. 2008. Age-specific prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health 43: S5-S25. e1-41. Tonon SA, Picconi MA, Zinovich JB, Liotta DJ, Bos PD, Galuppo JA, Alonio LV, Ferreras JA, Teyssié AR. 1999. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma. Infect Dis Obstet Gynecol 7: 237-243. Herbert J, Coffin J. 2008. Reducing patient risk for human papillomavirus infection and cervical cancer. J Am Osteopath Assoc 108: 65-70. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. 2006. HPV-mediated cervical carcinogenesis: Concepts and clinical implications. J Pathol 208: 152-164. Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJ, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR, de Sanjosé S, Molano M, Matos E, Ferreccio C, Anh PT, Thomas JO, Meijer CJ, IARC HPV Prevalence Surveys Study Group. 2006. Sexual behavior, condom use, and human papillomavirus: Pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 15: 326-333. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G, GlaxoSmithKline HPV Vaccine Study Group. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized controlled trial. Lancet 364: 1757-1765. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV Study PATRICIA Group. Greenacre M, 2009. Efficacy of human papillomavirus (HP oncogenic HPV types (PATRICIA): Final analysis of a double-blind randomised study in young women. Lancet 374: 301-314. Ault KA. The Future II Study Group. 2007. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomized clinical trial. Lancet 369: 1861-1868. Schwarz TF, Spaczynski M, Schneider A, Wysocki J, Galaj A, Perona P, Poncelet S, Zahaf T, Hardt K, Descamps D, Dubin G, HPV Study Group for Adult Women. 2009. Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine 27: 581-587. Muñoz N, Castellsagué X, Berrington de González A, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24: 1-10. Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, Studentsov YY, McAdams M, Schiffman M. 2004. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 13: 1574-1582. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. 2003. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol 157: 218-226. Erratum in: Am J Epidemiol 2003 157: 858. Lenselink CH, Melchers WJ, Quint WG, Hoebers AM, Hendriks JC, Massuger LF, Bekkers RL. 2008. Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands. PLoS One 3: e3743. Chan PK, Ho WC, Wong MC, Chang AR, Chor JS, Yu MY. 2009. Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol 81: 1635-1644. Contoyannis P, Jones AM. 2004. Socio-economic status, health and lifestyle. J Health Econ 23: 965-995. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S, 2007. Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370: 1609-1621. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A, Survey of HPV in Ontario Women Group. 2003. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 168: 421-425. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A. 2009. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 101: 1612-1623. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19. Harper MD, Paavonen J. 2008. Age for HPV vaccination. Vaccine 26: A7-A11. Burchell AN, Winer RL, de Sanjose S, Franco EL. 2006. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 24: S52-S61. Venuti A, Badaracco G, Sedati A, Carbini R, Marcante ML. 1994. Determinants of human papillomavirus types 16 and 18 infections in the lower female genital tract in an Italian population. Eur J Gynaecol Oncol 15: 205-210. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G, HPV Vaccine Study Group. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized control trial. Lancet 367: 1247-1255. Schiffman MH, Castle P. 2003. Epidemiologic studies of a necessary causal risk factor: Human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 95: E2. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M. 2001. HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. Br J Cancer 84: 1219-1226. Schroder KE, Carey MP, Vanable PA. 2003. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med 26: 104-123. Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 3: 902-907. Castellsagué X, Schneider A, Kaufmann AM, Bosch FX. 2009. HPV vaccination against cervical cancer in women above 25 years of age: Key considerations and current perspectives. Gynecol Oncol 115: S15-S23. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjosè S, Bruni L, Tortolero-Luna G, Kruger Kjaer S, Muñoz N. 2008. Epidemiology and natural history of human papilloma virus infections and type-specific implications in cervical neoplasia. Vaccine 26: K1-K16. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, Lorincz A, Dalby DM, Janjusevic V, Keller JL. 2000. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 163: 503-508. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6: 271-278. Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G. 2008. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 26: L16-L36. Schlecht NF, Franco EL, Rohan TE, Kjaer SK, Schiffman MH, Moscicki AB, Duffy SW, Marsh International Collaborative Group. 2001. Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: Determinants of reporting error at follow-up interviews. J Epidemiol Biostat 6: 393-407. 2004; 364 2007; 369 2006; 95 2009; 81 2004; 23 2006; 15 2009; 374 2008 2008; 108 2002; 3 2006 2008; 3 1999; 189 1999; 7 2003; 95 2003; 157 2003; 31 2001; 84 2009; 27 2009; 115 2006; 208 2000; 38 2007; 370 2006; 24 2001; 6 2004; 13 2008; 26 2009; 101 2003; 26 2000; 163 2005; 6 2008; 43 1994; 15 2003; 168 2006; 367 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 Herbert J (e_1_2_7_16_1) 2008; 108 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 Venuti A (e_1_2_7_34_1) 1994; 15 Sellors JW (e_1_2_7_28_1) 2003; 168 e_1_2_7_30_1 e_1_2_7_25_1 Shields TS (e_1_2_7_29_1) 2004; 13 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 Leinonen M (e_1_2_7_19_1) 2009; 101 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 Sellors JW (e_1_2_7_27_1) 2000; 163 |
| References_xml | – volume: 208 start-page: 152 year: 2006 end-page: 164 article-title: HPV‐mediated cervical carcinogenesis: Concepts and clinical implications publication-title: J Pathol – volume: 26 start-page: 104 year: 2003 end-page: 123 article-title: Methodological challenges in research on sexual risk behavior: II. Accuracy of self‐reports publication-title: Ann Behav Med – volume: 163 start-page: 503 year: 2000 end-page: 508 article-title: Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group publication-title: CMAJ – volume: 374 start-page: 301 year: 2009 end-page: 314 article-title: Efficacy of human papillomavirus (HP oncogenic HPV types (PATRICIA): Final analysis of a double‐blind randomised study in young women publication-title: Lancet – volume: 23 start-page: 965 year: 2004 end-page: 995 article-title: Socio‐economic status, health and lifestyle publication-title: J Health Econ – volume: 3 start-page: e3743 year: 2008 article-title: Sexual behaviour and HPV infections in 18 to 29 year old women in the pre‐vaccine era in the Netherlands publication-title: PLoS One – volume: 81 start-page: 1635 year: 2009 end-page: 1644 article-title: Epidemiologic risk profile of infection with different groups of human papillomaviruses publication-title: J Med Virol – volume: 26 start-page: A7 year: 2008 end-page: A11 article-title: Age for HPV vaccination publication-title: Vaccine – volume: 27 start-page: 581 year: 2009 end-page: 587 article-title: Immunogenicity and tolerability of an HPV‐16/18 AS04‐adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years publication-title: Vaccine – volume: 168 start-page: 421 year: 2003 end-page: 425 article-title: Incidence, clearance and predictors of human papillomavirus infection in women publication-title: CMAJ – volume: 367 start-page: 1247 year: 2006 end-page: 1255 article-title: Sustained efficacy up to 4.5 years of a bivalent L1 virus‐like particle vaccine against human papillomavirus types 16 and 18: Follow‐up from a randomized control trial publication-title: Lancet – volume: 3 start-page: 902 year: 2002 end-page: 907 article-title: Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples publication-title: J Clin Microbiol – volume: 364 start-page: 1757 year: 2004 end-page: 1765 article-title: Efficacy of a bivalent L1 virus‐like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized controlled trial publication-title: Lancet – volume: 157 start-page: 218 year: 2003 end-page: 226 article-title: Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students publication-title: Am J Epidemiol – volume: 26 start-page: L16 year: 2008 end-page: L36 article-title: Risk factors for human papillomavirus exposure and co‐factors for cervical cancer in Latin America and the Caribbean publication-title: Vaccine – volume: 24 start-page: 1 year: 2006 end-page: 10 article-title: Chapter 1: HPV in the etiology of human cancer publication-title: Vaccine – volume: 15 start-page: 205 year: 1994 end-page: 210 article-title: Determinants of human papillomavirus types 16 and 18 infections in the lower female genital tract in an Italian population publication-title: Eur J Gynaecol Oncol – volume: 6 start-page: 271 year: 2005 end-page: 278 article-title: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus‐like particle vaccine in young women: A randomised double‐blind placebo‐controlled multicentre phase II efficacy trial publication-title: Lancet Oncol – volume: 108 start-page: 65 year: 2008 end-page: 70 article-title: Reducing patient risk for human papillomavirus infection and cervical cancer publication-title: J Am Osteopath Assoc – volume: 6 start-page: 393 year: 2001 end-page: 407 article-title: Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: Determinants of reporting error at follow‐up interviews publication-title: J Epidemiol Biostat – volume: 31 start-page: 3 year: 2003 end-page: 13 article-title: Chapter 1: Human papillomavirus and cervical cancer‐burden and assessment of causality publication-title: J Natl Cancer Inst Monogr – volume: 26 start-page: K1 year: 2008 end-page: K16 article-title: Epidemiology and natural history of human papilloma virus infections and type‐specific implications in cervical neoplasia publication-title: Vaccine – volume: 43 start-page: S5 year: 2008 end-page: S25 article-title: Age‐specific prevalence of infection with human papillomavirus in females: A global review publication-title: J Adolesc Health – volume: 7 start-page: 237 year: 1999 end-page: 243 article-title: Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma publication-title: Infect Dis Obstet Gynecol – year: 2008 – year: 2006 – volume: 38 start-page: 357 year: 2000 end-page: 361 article-title: Improved amplification of genital human papillomaviruses publication-title: J Clin Microbiol – volume: 101 start-page: 1612 year: 2009 end-page: 1623 article-title: Age‐specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting publication-title: J Natl Cancer Inst – volume: 24 start-page: S52 year: 2006 end-page: S61 article-title: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection publication-title: Vaccine – volume: 189 start-page: 12 year: 1999 end-page: 19 article-title: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide publication-title: J Pathol – volume: 15 start-page: 326 year: 2006 end-page: 333 article-title: Sexual behavior, condom use, and human papillomavirus: Pooled analysis of the IARC human papillomavirus prevalence surveys publication-title: Cancer Epidemiol Biomarkers Prev – volume: 95 start-page: 1459 year: 2006 end-page: 1466 article-title: High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus‐like particle vaccine through 5 years of follow‐up publication-title: Br J Cancer – volume: 370 start-page: 1609 year: 2007 end-page: 1621 article-title: Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies publication-title: Lancet – volume: 369 start-page: 1861 year: 2007 end-page: 1868 article-title: Effect of prophylactic human papillomavirus L1 virus‐like‐particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomized clinical trial publication-title: Lancet – volume: 95 start-page: E2 year: 2003 article-title: Epidemiologic studies of a necessary causal risk factor: Human papillomavirus infection and cervical neoplasia publication-title: J Natl Cancer Inst – volume: 84 start-page: 1219 year: 2001 end-page: 1226 article-title: HPV co‐factors related to the development of cervical cancer: Results from a population‐based study in Costa Rica publication-title: Br J Cancer – volume: 13 start-page: 1574 year: 2004 end-page: 1582 article-title: A case–control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus publication-title: Cancer Epidemiol Biomarkers Prev – volume: 115 start-page: S15 year: 2009 end-page: S23 article-title: HPV vaccination against cervical cancer in women above 25 years of age: Key considerations and current perspectives publication-title: Gynecol Oncol – ident: e_1_2_7_22_1 doi: 10.1016/S0140-6736(09)61248-4 – ident: e_1_2_7_25_1 doi: 10.1207/S15324796ABM2602_03 – ident: e_1_2_7_35_1 doi: 10.1016/S1470-2045(05)70101-7 – ident: e_1_2_7_36_1 doi: 10.1038/sj.bjc.6603469 – volume: 101 start-page: 1612 year: 2009 ident: e_1_2_7_19_1 article-title: Age‐specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djp367 contributor: fullname: Leinonen M – ident: e_1_2_7_30_1 doi: 10.1016/j.jadohealth.2008.07.009 – ident: e_1_2_7_7_1 doi: 10.1016/j.vaccine.2006.05.031 – ident: e_1_2_7_20_1 doi: 10.1371/journal.pone.0003743 – ident: e_1_2_7_3_1 – ident: e_1_2_7_8_1 doi: 10.1016/j.ygyno.2009.09.021 – ident: e_1_2_7_9_1 doi: 10.1002/jmv.21575 – ident: e_1_2_7_23_1 doi: 10.1093/jnci/95.6.E2 – volume: 15 start-page: 205 year: 1994 ident: e_1_2_7_34_1 article-title: Determinants of human papillomavirus types 16 and 18 infections in the lower female genital tract in an Italian population publication-title: Eur J Gynaecol Oncol contributor: fullname: Venuti A – ident: e_1_2_7_4_1 doi: 10.1016/S0140-6736(07)60852-6 – ident: e_1_2_7_13_1 doi: 10.1016/j.vaccine.2008.01.013 – ident: e_1_2_7_21_1 doi: 10.1016/j.vaccine.2006.05.115 – ident: e_1_2_7_37_1 doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F – volume: 108 start-page: 65 year: 2008 ident: e_1_2_7_16_1 article-title: Reducing patient risk for human papillomavirus infection and cervical cancer publication-title: J Am Osteopath Assoc contributor: fullname: Herbert J – volume: 13 start-page: 1574 year: 2004 ident: e_1_2_7_29_1 article-title: A case–control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.1574.13.10 contributor: fullname: Shields TS – ident: e_1_2_7_39_1 – ident: e_1_2_7_17_1 doi: 10.1054/bjoc.2001.1779 – ident: e_1_2_7_33_1 doi: 10.1158/1055-9965.EPI-05-0577 – ident: e_1_2_7_12_1 doi: 10.1128/JCM.38.1.357-361.2000 – ident: e_1_2_7_26_1 doi: 10.1016/j.vaccine.2008.10.088 – ident: e_1_2_7_15_1 doi: 10.1016/S0140-6736(06)68439-0 – volume: 163 start-page: 503 year: 2000 ident: e_1_2_7_27_1 article-title: Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group publication-title: CMAJ contributor: fullname: Sellors JW – ident: e_1_2_7_5_1 doi: 10.1093/oxfordjournals.jncimonographs.a003479 – ident: e_1_2_7_18_1 doi: 10.1016/S0140-6736(07)61684-5 – ident: e_1_2_7_31_1 doi: 10.1002/path.1866 – ident: e_1_2_7_2_1 doi: 10.1016/j.vaccine.2008.06.008 – ident: e_1_2_7_24_1 doi: 10.1080/135952201753337149 – ident: e_1_2_7_38_1 doi: 10.1093/aje/kwf180 – ident: e_1_2_7_14_1 doi: 10.1016/S0140-6736(04)17398-4 – ident: e_1_2_7_32_1 doi: 10.1002/(SICI)1098-0997(1999)7:5<237::AID-IDOG6>3.0.CO;2-4 – volume: 168 start-page: 421 year: 2003 ident: e_1_2_7_28_1 article-title: Incidence, clearance and predictors of human papillomavirus infection in women publication-title: CMAJ contributor: fullname: Sellors JW – ident: e_1_2_7_10_1 doi: 10.1016/j.jhealeco.2004.02.001 – ident: e_1_2_7_11_1 doi: 10.1128/JCM.40.3.902-907.2002 – ident: e_1_2_7_6_1 doi: 10.1016/j.vaccine.2008.05.064 |
| SSID | ssj0008922 |
| Score | 2.0424004 |
| Snippet | HPV infection is a "necessary cause" of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for... HPV infection is a “necessary cause” of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk factors for... Background: HPV infection is a “necessary cause” of cervical cancer and it is sexually transmitted. Due to upcoming mass vaccination investigation on risk... |
| SourceID | hal proquest crossref pubmed pascalfrancis wiley istex fao |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 1921 |
| SubjectTerms | Adolescent Adult Biological and medical sciences cervical cancer Epidemiology Female Fundamental and applied biological sciences. Psychology Genotype HPV Human viral diseases Humans Infectious diseases Italy - epidemiology Mass Screening Medical sciences Microbiology Miscellaneous Multivariate Analysis Papillomaviridae - classification Papillomaviridae - genetics Papillomaviridae - isolation & purification Papillomavirus Infections - diagnosis Papillomavirus Infections - epidemiology Papillomavirus Infections - virology Predictive Value of Tests Prevalence questionnaire Risk Factors Sexual Behavior Surveys and Questionnaires Viral diseases Virology Women's Health Young Adult |
| Title | Predictors of human papilloma virus (HPV) infection in Italian women |
| URI | https://api.istex.fr/ark:/67375/WNG-DM8Q7BZC-8/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.21887 https://www.ncbi.nlm.nih.gov/pubmed/20872720 https://search.proquest.com/docview/755400813 https://hal.science/hal-00577347 |
| Volume | 82 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fT9swED4NJk172QbbIAyQNaGJPWSkiRO74olRWEEr6sRgiBfLTuLxM6kaWu3P353TBFXapEl7iazIJ8V3Ofuz7-4zwFY3yWJEtRI9LZU-5zrwdWK4n4nEch2ZLHUVcv1TcXIhewdEk7Pb1MLU_BDtgRt5hpuvycG1qXYeSUNv7qefcH2SVEmOuwRXvhEN21lYdusIAs4EPq5BccMqFIQ7reTcWrRgdYnPK8qHfEoq_kV5krpCVdn6jos_gdB5TOsWpcOX_zWcV_BihkXZXv3zLMGTvFiGZ4NZtP019IZjatN9PKy0zF3nx0Z6dH13V95rNr0eTyq23R-ef2RNTleBLXb04A5PmGN3eANnhwff9_v-7NYFP-XEC5UgKOMiNLGN0VpJxrGVCtxs6tjwIDMm0damMtImQyiR5jyIpBFdG6Bx0egyeguLRVnkq8Aig_JEcWbzkCc6QFEcoU47WSfv6kh68L7RvxrV5BqqplEOFepDOX14sIqWUfonTnrq7DSkUGsHURbuFVEezdWKElN2f--rondUZCtwHNOOBx-cNdtuenxL2WwiVj9OvqjeQH4Tny_3FX7N5py5WwEEnTHFXz1gjf0VOiFFVnSRl5NKCQRlBK4iD1bq_-JROJAu1u3BtjP_3weqjgfnrrH2713fwXOXzuCKI9dh8WE8yTdgocomm84dfgOv-AYm |
| link.rule.ids | 230,315,782,786,887,1408,27933,27934,46064,46488 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_RTQJe-GYLH8NCCI2HsDRxYlfiZawbGbRV0T5Ae7HsJIbBllTtWvHnc-c0mSqBhMRLZVU5KfbPZ__iu_sZ4FUvyWNktRI9LZM-5zrwdWK4n4vEch2ZPHMVcumRGH2V_X2SyXnX1MLU-hDtgRt5hluvycHpQHrnWjX0x-XiLW5QUnRgnSc4EamAIxq367Ds1TEEXAt83IXiRlcoCHda05XdqGN1hb_fKSNynQb5F2VK6hkOlq1vufgTDV1ltW5bOrj7fx26B3eWdJTt1vPnPtwoygdwc7gMuD-E_nhKbbqSh1WWuRv92ERPzi8uqkvNFufT-Yxtp-PTN6xJ6yqxxQ6v3PkJcwIPj-DkYP94L_WXFy_4GSdpqAR5GRehiW2MgCU5x1Ym8HtTx4YHuTGJtjaTkTY5soms4EEkjejZAPFF3GX0GNbKqiw2gUUG7UnlzBYhT3SApthDnXXzbtHTkfTgZQOAmtT6GqpWUg4Vjody4-HBJkKj9Ddc99TJUUjR1i4SLfxcRHvEqzUlsex0d6DoP6qzFdiPRdeD1w7O9jE9_UkJbSJWX0YfVH8oP4v3Z3sK32ZrBe_WAHlnTCFYD1gzART6IQVXdFlU85kSyMuIX0UebNQT49o4kC7c7cG2w__vHVUfh6eu8eTfH30Bt9Lj4UANDkefnsJtl93gaiWfwdrVdF48h84sn2853_gNRHQKTg |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED7RTZp42fi9MDYshNB4CEsTJ3bF01hXOlirorEN8WLZSTwGW1K1a8WfvzunyVQJJCReIivKSfF9OfuL7_wZ4HUnyWJktRIjLZU-5zrwdWK4n4nEch2ZLHU75PonYvhNdg9JJud9vRem0odoFtwoMtx4TQE-zuzenWjoz-v5O5yfpGjBKkcaTsL5UTRqhmHZqVIIOBT4OAnFtaxQEO41pkuTUcvqEq8_qCBylXz8mwol9RR9ZatDLv7EQpdJrZuVehv_1Z8HsL4go2y_-noewr28eARrg0W6_TF0RxNq04E8rLTMnefHxnp8eXVVXms2v5zMpmy3Pzp7y-qirgJb7OjGrZ4wJ-_wBE57h18P-v7i2AU_5SQMlSAr4yI0sY0RriTj2EoF_m3q2PAgMybR1qYy0iZDLpHmPIikER0bILqIuoyewkpRFvkmsMigPWmc2TzkiQ7QFHuo03bWzjs6kh68qv2vxpW6hqp0lEOF_lDOHx5sIjJKX-Cop05PQsq1tpFm4c8i2iNcjSlJZff3jxXdo122Avsxb3vwxqHZPKYnv6icTcTqfPhRdQfyi_jw_UDh2-wswd0YIOuMKQHrAavxVxiFlFrRRV7OpkogKyN2FXnwrPou7owD6ZLdHuw6-P_eUfVpcOYaz__90ZewNur21PHR8PMW3HelDW6j5AtYuZnM8m1oTbPZjouMW_UcCPQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+of+human+papilloma+virus+%28HPV%29+infection+in+Italian+women&rft.jtitle=Journal+of+medical+virology&rft.au=Cercato%2C+M.C.&rft.au=Mariani%2C+L.&rft.au=Vocaturo%2C+A.&rft.au=Carrone%2C+A.&rft.date=2010-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0146-6615&rft.eissn=1096-9071&rft.volume=82&rft.issue=11&rft.spage=1921&rft.epage=1927&rft_id=info:doi/10.1002%2Fjmv.21887&rft.externalDBID=10.1002%252Fjmv.21887&rft.externalDocID=JMV21887 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon |